Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease

Read full text
Authors: Diana Esteller-Gauxax, Núria Guillén, Neus Falgàs, Beatríz Bosch, Adrià Tort‐Merino, Sergi Borrego‐Écija, Roger Puey, Raquel Ruiz‐Garcia, Laura Naranjo, Aida Niñerola‐Baizán, Andrés Perissinotti, Núria Bargalló
+6 more Anna Antonell, Albert Lladó, Raquel Sánchez‐Valle, Agnès Pérez-Millan, Mircea Balasa, for the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Cited by: 1
References: 32

Abstract

INTRODUCTION: Brain atrophy patterns in Alzheimer's disease (AD) are well established, however, the contribution of alpha-synuclein (α-syn) copathology to these patterns remains unclear. This study investigates magnetic resonance imaging (MRI) -based atrophy patterns in AD patients with α-syn copathology. METHODS: = 191). Participants were classified into AD-α-syn seed amplification assay positive (αSAA+), AD-αSAA-, and healthy controls (CTR). Group comparisons of MRI regions were conducted using permutation tests adjusting for age and sex. RESULTS: Compared to CTR, both AD-αSAA- and AD-αSAA+ showed widespread cortical thinning. Direct comparison of AD-αSAA+ versus AD-αSAA- revealed differential involvement of insular, entorhinal, lateral temporal, pre and postcentral gyrus, frontal cortices, and amygdala, although with minimum size effect. DISCUSSION: α-Syn copathology was associated with more extensive and pronounced atrophy, especially in frontal, lateral temporal, entorhinal, and amygdalar regions. This suggests that α-syn is associated with greater neurodegeneration beyond typical AD patterns.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Dementia and Cognitive Impairment Research Functional Brain Connectivity Studies

Publication details

Journal / source
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Publisher
Wiley
Volume
18
Issue
2
Pages
e70347–e70347
Publication date
1 April 2026
Language
EN